Pasar al contenido principal

DISEÑO DE COMPLEJOS METALICOS MULTIFUNCIONALES PARA LA FOTOTERAPIA DE CELULAS MADRE TUMORALES

PID2021-122850NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE MURCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

A near-infrared light-activatable Ru(ii)-coumarin photosensitizer active under hypoxic conditions

  • Ortega Forte, Enrique
  • Rovira, Anna
  • López Corrales, Marta
  • Hernández García, Alba
  • Ballester, Francisco José
  • Izquierdo García, Eduardo
  • Jordà-Redondo, Mireia
  • Bosch, Manel
  • Nonell, Santi
  • Santana, María Dolores
  • Ruiz, José
  • Marchán, Vicente
  • Gasser, Gilles
Photodynamic therapy (PDT) represents a promising approach for cancer treatment. However, the oxygen dependency of PDT to generate reactive oxygen species (ROS) hampers its therapeutic efficacy, especially against hypoxic solid tumors. In addition, some photosensitizers (PSs) have dark toxicity and are only activatable with short wavelengths such as blue or UV-light, which suffer from poor tissue penetration. Herein, we developed a novel hypoxia-active PS with operability in the near-infrared (NIR) region based on the conjugation of a cyclometalated Ru(II) polypyridyl complex of the type [Ru(C^N)(N^N)2] to a NIR-emitting COUPY dye. The novel Ru(II)-coumarin conjugate exhibits water-solubility, dark stability in biological media and high photostability along with advantageous luminescent properties that facilitate both bioimaging and phototherapy. Spectroscopic and photobiological studies revealed that this conjugate efficiently generates singlet oxygen and superoxide radical anions, thereby achieving high photoactivity toward cancer cells upon highly-penetrating 740 nm light irradiation even under hypoxic environments (2% O2). The induction of ROS-mediated cancer cell death upon low-energy wavelength irradiation along with the low dark toxicity exerted by this Ru(II)-coumarin conjugate could circumvent tissue penetration issues while alleviating the hypoxia limitation of PDT. As such, this strategy could pave the way to the development of novel NIR- and hypoxia-active Ru(II)-based theragnostic PSs fuelled by the conjugation of tunable, low molecular-weight COUPY fluorophores., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Achieving red-light anticancer photodynamic therapy under hypoxia using Ir(iii)–COUPY conjugates

  • Ortega-Forte, Enrique
  • Rovira, Anna
  • Ashoo, Pezhman
  • Izquierdo García, Eduardo
  • Hally, Cormac
  • Abad-Montero, Diego
  • Jordà-Redondo, Mireia
  • Vigueras Bautista, Gloria
  • Deyà, Alba
  • Hernández, José Luis
  • GALINO, JORGE
  • Bosch, Manel
  • Alberto, Marta Erminia
  • Francés-Monerris, Antonio
  • Nonell, Santi
  • Ruiz, Jose
  • Marchán, Vicente
Despite the potential of photodynamic therapy (PDT), this oxygen-dependent oncological treatment is greatly restricted in the clinic by the well-known hypoxic feature of solid tumors. Here we provide new insights into the development of PDT agents based on conjugates between COUPY fluorophores and cyclometalated iridium(III) complexes with the aim of overcoming this limitation. The structural modifications carried out within the metal core of Ir(III)–COUPY conjugates, based on the incorporation of trifluorobenzyl groups at the cyclometalating ligands, enabled efficient exploitation of type I PDT mechanisms while retaining operativity under long-wavelength visible light, which facilitated deeper tissue penetration compared with short wavelengths. Photobiological evaluation revealed that Ir(III)–COUPY conjugate 3c achieved potent photocytotoxicity towards cisplatin-resistant ovarian (A2780cis) and mammary (EO771) cancer cell lines, efficiently photogenerated type I and type II ROS, and photoinduced apoptotic cell death using red light irradiation (620 nm). Importantly, this Ir(III)–COUPY conjugate retained such potent photoactivity under low-oxygen environment conditions (2% O2), delivering equipotent photocytotoxicity towards normoxic and hypoxic adherent cancer cells. Compound 3c was found to be highly phototoxic against EO771 multicellular tumor spheroids and showed no signs of toxicity or adverse effects in mice, which could facilitate in vivo phototherapeutic applications. Taken together, this study demonstrates that the conjugation between COUPY dyes and rationally designed Ir(III) complexes is a strategy at the frontier of the development of new red light-activated photosensitizers capable of operating under hypoxia, showing the promise of achieving satisfactory anticancer PDT effects., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring structure-activity relationships in photodynamic therapy anticancer agents based on Ir(III)-COUPY conjugates

  • Rovira, Anna
  • Ortega-Forte, Enrique
  • Hally, Cormac
  • Jordà-Redondo, Mireia
  • Abad-Montero, Diego
  • Vigueras, Gloria
  • Martínez, Jesús I.
  • Bosch, Manel
  • Nonell, Santi
  • Ruiz, José
  • Marchán, Vicente
Photodynamic therapy holds great promise as a non-invasive anticancer tool against drug-resistant cancers. However, highly effective, non-toxic, and reliable photosensitizers with operability under hypoxic conditions remain to be developed. Herein, we took the advantageous properties of COUPY fluorophores and cyclometalated Ir(III) complexes to develop novel PDT agents based on Ir(III)-COUPY conjugates with the aim of exploring structure-activity relationships. The structural modifications carried out within the coumarin scaffold had a strong impact on the photophysical properties and cellular uptake of the conjugates. All Ir(III)-COUPY conjugates exhibited high phototoxicity under green light irradiation, which was attributed to the photogeneration of ROS, while remaining non-toxic in the dark. Among them, two hit conjugates showed excellent phototherapeutic indexes in cisplatin-resistant A2780cis cancer cells, both in normoxia and in hypoxia, suggesting that photoactive therapy approaches based on the conjugation of far-red/NIR-emitting COUPY dyes and transition metal complexes could effectively tackle in vitro acquired resistance to cisplatin., This work was supported by funds from the Spanish Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación (MCI/AEI/10.13039/501100011033) and FEDER funds (Projects CTQ2017-84779-R, RTI2018-096891-B-I00, PID2020-117508RB-I00, PID2021-122850NB-I00, CTQ2016-78454-C2-1-R, and PID2020-115801RB-C22)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Exploring structure–activity relationships in photodynamic therapy anticancer agents based on Ir(III)-COUPY conjugates

  • Rovira, A.
  • Ortega-Forte, E.
  • Hally, C.
  • Jordà-Redondo, M.
  • Abad-Montero, D.
  • Vigueras, G.
  • Martínez, J. I.
  • Bosch, M.
  • Nonell, S.
  • Ruiz, J.
  • Marchán, V.
Photodynamic therapy holds great promise as a non-invasive anticancer tool against drug-resistant cancers. However, highly effective, non-toxic, and reliable photosensitizers with operability under hypoxic conditions remain to be developed. Herein, we took the advantageous properties of COUPY fluorophores and cyclometalated Ir(III) complexes to develop novel PDT agents based on Ir(III)-COUPY conjugates with the aim of exploring structure–activity relationships. The structural modifications carried out within the coumarin scaffold had a strong impact on the photophysical properties and cellular uptake of the conjugates. All Ir(III)-COUPY conjugates exhibited high phototoxicity under green light irradiation, which was attributed to the photogeneration of ROS, while remaining non-toxic in the dark. Among them, two hit conjugates showed excellent phototherapeutic indexes in cisplatin-resistant A2780cis cancer cells, both in normoxia and in hypoxia, suggesting that photoactive therapy approaches based on the conjugation of far-red/NIR-emitting COUPY dyes and transition metal complexes could effectively tackle in vitro acquired resistance to cisplatin.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Achieving red-light anticancer photodynamic therapy under hypoxia using Ir(iii)–COUPY conjugates

  • Ortega-Forte, Enrique
  • Rovira, Anna
  • Ashoo, Pezhman
  • Izquierdo García, Eduardo
  • Hally, Cormac
  • Abad-Montero, Diego
  • Jordà-Redondo, Mireia
  • Vigueras Bautista, Gloria
  • Deyà, Alba
  • Hernández, José Luis
  • GALINO, JORGE
  • Bosch, Manel
  • Alberto, Marta Erminia
  • Francés-Monerris, Antonio
  • Nonell, Santi
  • Ruiz, Jose
  • Marchán, Vicente
Despite the potential of photodynamic therapy (PDT), this oxygen-dependent oncological treatment is greatly restricted in the clinic by the well-known hypoxic feature of solid tumors. Here we provide new insights into the development of PDT agents based on conjugates between COUPY fluorophores and cyclometalated iridium(III) complexes with the aim of overcoming this limitation. The structural modifications carried out within the metal core of Ir(III)–COUPY conjugates, based on the incorporation of trifluorobenzyl groups at the cyclometalating ligands, enabled efficient exploitation of type I PDT mechanisms while retaining operativity under long-wavelength visible light, which facilitated deeper tissue penetration compared with short wavelengths. Photobiological evaluation revealed that Ir(III)–COUPY conjugate 3c achieved potent photocytotoxicity towards cisplatin-resistant ovarian (A2780cis) and mammary (EO771) cancer cell lines, efficiently photogenerated type I and type II ROS, and photoinduced apoptotic cell death using red light irradiation (620 nm). Importantly, this Ir(III)–COUPY conjugate retained such potent photoactivity under low-oxygen environment conditions (2% O2), delivering equipotent photocytotoxicity towards normoxic and hypoxic adherent cancer cells. Compound 3c was found to be highly phototoxic against EO771 multicellular tumor spheroids and showed no signs of toxicity or adverse effects in mice, which could facilitate in vivo phototherapeutic applications. Taken together, this study demonstrates that the conjugation between COUPY dyes and rationally designed Ir(III) complexes is a strategy at the frontier of the development of new red light-activated photosensitizers capable of operating under hypoxia, showing the promise of achieving satisfactory anticancer PDT effects., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A near-infrared light-activatable Ru(ii)-coumarin photosensitizer active under hypoxic conditions

  • Ortega Forte, Enrique
  • Rovira, Anna
  • López Corrales, Marta
  • Hernández García, Alba
  • Ballester, Francisco José
  • Izquierdo García, Eduardo
  • Jordà-Redondo, Mireia
  • Bosch, Manel
  • Nonell, Santi
  • Santana, María Dolores
  • Ruiz, José
  • Marchán, Vicente
  • Gasser, Gilles
Photodynamic therapy (PDT) represents a promising approach for cancer treatment. However, the oxygen dependency of PDT to generate reactive oxygen species (ROS) hampers its therapeutic efficacy, especially against hypoxic solid tumors. In addition, some photosensitizers (PSs) have dark toxicity and are only activatable with short wavelengths such as blue or UV-light, which suffer from poor tissue penetration. Herein, we developed a novel hypoxia-active PS with operability in the near-infrared (NIR) region based on the conjugation of a cyclometalated Ru(II) polypyridyl complex of the type [Ru(C^N)(N^N)2] to a NIR-emitting COUPY dye. The novel Ru(II)-coumarin conjugate exhibits water-solubility, dark stability in biological media and high photostability along with advantageous luminescent properties that facilitate both bioimaging and phototherapy. Spectroscopic and photobiological studies revealed that this conjugate efficiently generates singlet oxygen and superoxide radical anions, thereby achieving high photoactivity toward cancer cells upon highly-penetrating 740 nm light irradiation even under hypoxic environments (2% O2). The induction of ROS-mediated cancer cell death upon low-energy wavelength irradiation along with the low dark toxicity exerted by this Ru(II)-coumarin conjugate could circumvent tissue penetration issues while alleviating the hypoxia limitation of PDT. As such, this strategy could pave the way to the development of novel NIR- and hypoxia-active Ru(II)-based theragnostic PSs fuelled by the conjugation of tunable, low molecular-weight COUPY fluorophores., info:eu-repo/semantics/publishedVersion